Language selection

Search

Details for: ENBREL

Company: IMMUNEX CORPORATION

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02242903ENBRELETANERCEPT; WATER25 MG / KIT; 1 ML / KITPOWDER FOR SOLUTIONSUBCUTANEOUS
02242903ENBRELETANERCEPT; WATER25 MG / KIT; 1 ML / KITLIQUIDSUBCUTANEOUS
02242903ENBRELETANERCEPT; WATER25 MG / KIT; 1 ML / KITKITSUBCUTANEOUS
02274728ENBRELETANERCEPT50 MG / MLSOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Regulatory Decision Summary
Summary Safety Review - ENBREL (etanercept) - Assessing the potential harm to the developing babies of mothers treated with ENBREL
Summary Safety Review - ENBREL (etanercept) - Schizophrenia like symptoms
Summary Safety Review - Tumour necrosis factor (TNF) blockers - Glioblastoma (brain tumour)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: